Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign

NCT02625948 is registered in ClinicalTrials.gov with Ministry of Science and Technology of the People´s Republic of China as lead sponsor.

NCT NCT02625948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
Lead sponsor
Ministry of Science and Technology of the People´s Republic of China
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2015
Completion date
Not reported
Enrollment
240 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage, stroke